(a) Expression of SIAH1 in the renal cortex of WT and Tg26 mice as determined by real-time PCR, n=5. (b) Western blots of SIAH1, HIPK2 and β-actin in the kidney cortex of WT and Tg26 mice, n=3. (c) Immunostaining of SIAH1 and HIPK2 in adjacent kidney sections of Tg26 and WT mice. (d) Western blots of SIAH1, HIPK2, and β-actin in human renal tubular epithelial cells (hRTECs) infected with a control virus (CL) or a pseudotyped HIV-1 virus (HIV). (e) Expression of SIAH1 in hRTEC infected with CL or HIV as quantified by real-time PCR, n=4 (f) Western blots of SIAH-1, HIPK2, and β-actin in hRTEC transfected with a specific siRNA to knockdown SIAH1 (siRNA), a negative control siRNA oligo (Oligo), an empty expression vector (Vector), or a SIAH1 expression vector (SIAH1). Western blots of hRTECs cultured in the presence of H2O2 (0, 10, 20, 50 μM) for 24 hr (g), treated with adriamycin (0, 10, and 50μM) for 24 hr (h), or infected with CL or HIV and then cultured in the presence and absence of N-acetylcystein (NAC; 10mM) for 3 days (i). (j) Immunostaining of HIPK2 and SIAH1 in patients with minimal change disease (MCD), HIVAN (early and late stages), idiopathic focal segmental glomerulosclerosis (FSGS), diabetic nephropathy (DN), IgA nephropathy (IgAN), and normal nephrectomy samples (Normal). Representative fields of glomeruli (Glom) and tubules (Tub) are shown. Semi-quantitative scoring of staining results is summarized in Supplementary Table c. All error bars represent s.d. *p<0.01 compared to WT. **p<0.05 compared to CL. Scale bar, 50μm